DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Estratest (Esterified Estrogens) - Adverse Event Reports - All Cases - Breast Cancer Female

 



Index of reports > All cases (48) > Cases with Breast Cancer Female (14)

Below is the selection of adverse event reports related to Estratest (Esterified Estrogens) that includes all cases where reactions include breast cancer female.

Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-10-25

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-10-23

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1996-01-01
    End date: 2004-11-01

Cycrin
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Estratest
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-07-31

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Adverse event resulted in: death

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Premarin
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Estratest
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Estrace
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-07-06

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: oral
    Administration route: Oral

Estradiol
    Dosage: oral
    Administration route: Oral

Cycrin
    Dosage: oral
    Administration route: Oral

Estratest
    Dosage: oral
    Administration route: Oral

Premarin
    Dosage: oral
    Administration route: Oral

Prempro
    Dosage: oral
    Administration route: Oral



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-06-12

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate(medroxyprogesterone Acetate(medroxyprogest
    Dosage: oral
    Administration route: Oral

Estradiol
    Dosage: oral
    Administration route: Oral

Cycrin
    Dosage: oral
    Administration route: Oral

Estrace
    Dosage: oral
    Administration route: Oral

Estratest
    Dosage: oral
    Administration route: Oral

Premarin
    Dosage: oral
    Administration route: Oral

Prempro
    Dosage: oral
    Administration route: Oral



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-04-17

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Adverse event resulted in: death

Suspect drug(s):
Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Prempro
    Indication: Hormone Replacement Therapy

Estratest
    Indication: Hormone Replacement Therapy



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-03-30

Patient: female

Adverse reactions / side effects: Diabetes Mellitus, Breast Cancer Female, Pancreatitis, Oestrogen Receptor Assay Positive, Progesterone Receptor Assay Positive, Cerebrovascular Accident

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01

Depo-Provera
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01

Alesse
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1986-01-01
    End date: 2002-01-01



Adverse event in 58 year old female receiving Estratest (Esterified Estrogens)

Reported by a physician from United States on 2007-03-15

Patient: 58 year old female

Adverse reactions / side effects: Pulmonary Hypertension, Biopsy Breast Abnormal, Diabetes Mellitus, Dilatation Ventricular, Tricuspid Valve Incompetence, Treatment Noncompliance, Surgery, Atrial Hypertrophy, Oedema Peripheral, Breast Hyperplasia, Echocardiogram, Back Pain, Supraventricular Tachycardia, Breast Cancer Female, Cholelithiasis, Ventricular Dysfunction, Cholecystectomy, Homicidal Ideation, Scan Myocardial Perfusion Abnormal, Head Injury, Breast Cancer Stage IV, Pain, Hemiparesis, Fall, Fatigue, Fibrocystic Breast Disease, Coronary Artery Bypass, Dizziness, Lymphoedema, Atrial Flutter, Urinary Tract Infection, Atrial Fibrillation, Cerebrovascular Accident, Cardiac Pacemaker Insertion, Arthralgia, Mitral Valve Incompetence, Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Vivelle
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Premarin
    Dosage: 10 mg, unk
    Administration route: Oral
    End date: 1996-08-01

Provera
    Dosage: 0.625 mg, unk
    Administration route: Oral
    End date: 1996-08-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Curretab
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Estrace
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

MPA
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Prempro
    Dosage: 0.625/25 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1996-08-01
    End date: 2002-08-01



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-03-08

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2003-01-01

Cycrin
    Dosage: oral
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2003-01-01

Estratest
    Dosage: oral
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2003-01-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2003-01-01

Prempro
    Dosage: oral
    Start date: 1995-01-01
    End date: 2003-01-01

Provera
    Dosage: orfal
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2003-01-01



Adverse event in 59 year old female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-02-21

Patient: 59 year old female, weighing 70.7 kg (155.5 pounds)

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Climara
    Dosage: 0.05 mg/d, cont, transdermal
    Indication: Menopausal Symptoms
    Start date: 1997-01-01
    End date: 1998-01-01

Premarin
    Dosage: 0.625 mg
    Indication: Menopausal Symptoms
    Start date: 1991-01-01
    End date: 1994-01-01

Ogen
    Dosage: 1.25 mg
    Indication: Menopausal Symptoms
    Start date: 1991-01-01
    End date: 1991-01-01

Provera
    Dosage: 10 mg
    Indication: Menopausal Symptoms
    Start date: 1991-01-01

Estratest
    Indication: Menopausal Symptoms
    Start date: 1991-01-01
    End date: 1992-01-01

Estrace
    Dosage: 1 mg
    Indication: Menopausal Symptoms
    Start date: 1992-01-01
    End date: 1997-01-01

Medroxyprogesterone
    Dosage: 10 g
    Indication: Menopausal Symptoms
    Start date: 1993-01-01
    End date: 1995-01-01

Activella
    Indication: Menopausal Symptoms
    Start date: 2000-01-01
    End date: 2001-01-01

Prempro
    Indication: Menopausal Symptoms

Menest
    Dosage: 3 mg
    Indication: Menopausal Symptoms
    Start date: 1999-01-01
    End date: 2000-01-01

Estratab
    Dosage: 3 mg
    Indication: Menopausal Symptoms
    Start date: 1998-01-01
    End date: 1999-01-01



Adverse event in 51 year old female receiving Estratest (Esterified Estrogens)

Reported by a pharmacist from United States on 2007-02-21

Patient: 51 year old female, weighing 58.1 kg (127.8 pounds)

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Climara
    Dosage: see image
    Indication: Menopausal Symptoms
    Start date: 2001-01-01
    End date: 2001-01-01

Climara
    Dosage: see image
    Indication: Menopausal Symptoms
    Start date: 2001-01-01
    End date: 2002-01-01

Premarin
    Indication: Menopausal Symptoms
    Start date: 1998-01-01
    End date: 2003-01-01

Estratest
    Indication: Menopausal Symptoms
    Start date: 1999-01-01
    End date: 2001-01-01

Other drugs received by patient: Lipitor / NET / (Atorvastatin Calcium); Synthroid; Fosamax; Miacalcin; Levaquin



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-01-30

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Estradiol
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Cycrin
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Estrace
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Estratest
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Premarin
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Prempro
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01

Provera
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1989-01-01
    End date: 2001-02-01



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer on 2007-01-29

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Medroxyprogesterone Acetate Tablet
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Estradiol
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01

Estrace
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2001-02-01



Adverse event in female receiving Estratest (Esterified Estrogens)

Reported by a lawyer from United States on 2007-01-11

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2002-07-01

Estratest
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2002-07-01

Cycrin
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2002-07-01

Premphase (Premarin;cycrin 14 / 14)
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2002-07-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2002-07-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2002-07-01

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009